Brief: Cytodyn Inc - New 3 Critically Ill COVID-19 Patients Treated With Leronlimab
30/03/2020 13:04
March 30 (Reuters) - Cytodyn Inc CYDY.PK :
* CYTODYN INC - AN ADDITIONAL THREE CRITICALLY ILL COVID-19
PATIENTS HAVE BEEN TREATED WITH LERONLIMAB
Source text for Eikon: ID:nGNX6n95nQ
Further company coverage: CYDY.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer